SIGNPATH PHARMA, INC. Derivative Liability, Fair Value, Gross Asset
SIGNPATH PHARMA, INC. had Derivative Liability, Fair Value, Gross Asset of -$5.69 million as of 2012-12-31, per its 10-K filed 2014-03-31.
Discontinued › Notes › Derivative Liability, Subject to Master Netting Arrangement, before Offset of Collateral
us-gaap:DerivativeLiabilityFairValueGrossAsset · last filed 2014-03-31
- 2012-12-31: Derivative Liability, Fair Value, Gross Asset -$5.69M.
- 2011-12-31: Derivative Liability, Fair Value, Gross Asset -$5.38M.
| Period end | Derivative Liability, Fair Value, Gross Asset |
|---|---|
| 2012-12-31 | -$5.69M 10-K · filed 2014-03-31 |
| 2011-12-31 | -$5.38M 10-K · filed 2013-04-01 |